Pei, Tao
Arrowhead Pharmaceuticals (United States)
2 papers on CoChatORCID 0000-0002-0875-2114
Most cited papers
- Verified
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)
Koren, M. J., Moriarty, P. M., Baum, S. J., Neutel, J., Hernandez-Illas, M., Weintraub, H. S., Florio, M., Kassahun, H., Melquist, S., Varrieur, T., et al. (2022) · Nature Medicine
Lipoproteins and Cardiovascular HealthRNA Interference and Gene Delivery
Cited by 239
- Verified
A clinical-stage RNAi therapeutic candidate for IPF mediates durable MMP7 silencing in nonhuman primates and human lung tissue
Yuan, T., Klossowski, S., Afrazi, M., Hamilton, H., Hegge, J., Hamilton, J., Pei, T., & Bush, E. (2023) · Idiopathic interstitial pneumonias
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisRNA Interference and Gene Delivery
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free